Cite
Impact of Additive Use of Olmesartan in Patients With Chronic Heart Failure: The Supplemental Benefit of an Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan.
MLA
Yasuhiko Sakata, et al. “Impact of Additive Use of Olmesartan in Patients With Chronic Heart Failure: The Supplemental Benefit of an Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan.” Circulation, vol. 130, no. 23, Dec. 2014, p. 2116. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=99910972&authtype=sso&custid=ns315887.
APA
Yasuhiko Sakata, Nobuyuki Shiba, Jun Takahashi, Satoshi Miyata, Kotaro Nochioka, Masanobu Miura, Tsuyoshi Takada, & Hiroaki Shimokawa. (2014). Impact of Additive Use of Olmesartan in Patients With Chronic Heart Failure: The Supplemental Benefit of an Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan. Circulation, 130(23), 2116.
Chicago
Yasuhiko Sakata, Nobuyuki Shiba, Jun Takahashi, Satoshi Miyata, Kotaro Nochioka, Masanobu Miura, Tsuyoshi Takada, and Hiroaki Shimokawa. 2014. “Impact of Additive Use of Olmesartan in Patients With Chronic Heart Failure: The Supplemental Benefit of an Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan.” Circulation 130 (23): 2116. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=99910972&authtype=sso&custid=ns315887.